Dr. Thummalapalli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
160 East 53rd Street
New York, NY 10022
Education & Training
Johns Hopkins UniversityResidency, Internal Medicine, 2018 - 2021
Harvard Medical SchoolClass of 2017
Certifications & Licensure
NY State Medical License 2021 - 2026
NJ State Medical License 2024 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsCheckpoint inhibitor-induced autoimmune encephalitis reversed by rituximab after allogeneic bone marrow transplant in a patient with Hodgkin lymphoma.Rohit Thummalapalli, Laura A. Sena, John C. Probasco, Douglas E. Gladstone
Leukemia & Lymphoma. 2020-01-02 - 6 citationsImmune Checkpoint Inhibitors in AML-A New Frontier.Rohit Thummalapalli, Hanna A. Knaus, Ivana Gojo, Joshua F. Zeidner
Current Cancer Drug Targets. 2020-01-01 - 189 citationsTumor innate immunity primed by specific interferon-stimulated endogenous retrovirusesIsrael Cañadas, Rohit Thummalapalli, Jong Wook Kim, Shunsuke Kitajima, Russell W. Jenkins
Nature Medicine. 2018-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
